Uterine cancer, also known as endometrial cancer, is one of the most common gynecologic cancers affecting women.
Uterine cancer — most commonly endometrial cancer, which begins in the inner lining of the uterus — is one of the most frequently diagnosed gynaecological cancers in women. Early detection of uterine cancer is possible because the most common warning sign, abnormal uterine bleeding, is difficult to ignore. With timely diagnosis and advanced uterine cancer treatment by a subspecialty-trained gynaecological oncologist, survival rates and treatment outcomes are highly successful.
Dr. Raj Kiran is a DrNB-qualified female gynaecological oncologist in North Delhi with expertise in robotic and laparoscopic staging surgery for uterine cancer. She consults at BLK-Max Super Speciality Hospital, Pusa Road, and Max Super Speciality Hospital, Shalimar Bagh.
Uterine cancer often shows early warning signs, making timely diagnosis and treatment possible. Abnormal bleeding should never be ignored, especially after menopause. Consult a gynaecological oncologist if you experience any of the following symptoms:
Post-menopausal bleeding is the single most important warning sign of endometrial cancer. Even a small amount of vaginal bleeding after menopause requires immediate medical evaluation by a gynaecological oncologist.
Certain medical, hormonal, and lifestyle factors can significantly increase the risk of developing uterine cancer or endometrial cancer.
Excess body fat increases oestrogen production, which directly stimulates the endometrium and raises endometrial cancer risk.
Chronic hormonal imbalance and unopposed oestrogen exposure increase the likelihood of uterine cancer.
Women with diabetes or insulin resistance have a higher incidence of endometrial cancer.
Women who have never been pregnant are at a relatively higher risk of developing uterine cancer.
Menopause after the age of 55 increases prolonged hormonal exposure and raises cancer risk.
Long-term use of oestrogen-only HRT without progesterone can increase the risk of endometrial cancer.
Women taking tamoxifen for breast cancer treatment may have a slightly increased risk of uterine cancer.
A family history of endometrial, colorectal, ovarian, or Lynch syndrome-related cancers increases the risk significantly.
Women with multiple risk factors should consider proactive screening and regular consultations with a gynaecological oncologist, even if no symptoms are currently present.
Accurate diagnosis and staging are essential before starting uterine cancer treatment. A structured diagnostic approach helps determine the extent of disease and guides personalised treatment planning.
Uterine cancer treatment is personalised based on cancer stage, tumour type, age, and overall health. Surgery is the most common and effective treatment for early-stage disease.
External beam radiation or vaginal brachytherapy may be recommended after surgery to reduce recurrence risk.
Progesterone-based hormonal treatment may help selected low-grade and fertility-preserving cases.
Advanced expertise in uterine cancer treatment with minimally invasive, robotic, and fertility-focused gynaecological oncology care.
Specialised DrNB training in gynaecological oncology and surgical treatment of uterine cancer.
Advanced robotic and laparoscopic surgery for faster recovery, minimal pain, and better surgical precision.
Smaller incisions, reduced blood loss, shorter hospital stays, and quicker return to daily life.
Targeted lymph node mapping helps reduce unnecessary surgery and lowers the risk of lymphoedema.
Conservative hormonal management for carefully selected young women with early-stage disease.
Consultation and surgery available at BLK-Max Super Speciality Hospital and Max Super Speciality Hospital, Shalimar Bagh.